How to Cancel Dialysis of Drugs

Learn how to cancel Dialysis of Drugs subscription on iPhone, Android, Paypal or directly.

Table of Contents:

1. Cancel on iphone
2. Cancel on android
3. Cancel on Paypal
4. Cancel via Email
5. Cancel on Website

Reading time: 41 seconds

Cancel Dialysis of Drugs Subscription on iPhone & iPad

1. On your phone, open "Settings" and tap your Apple ID profile.
2. Click "Subscriptions" and select "Dialysis of Drugs".
3. Click "Cancel Subscription" and confirm the cancellation.

Alternative method via AppStore:

1. Goto the Appstore » your Profile » Subscriptions.
2. select "Dialysis of Drugs" and click "Cancel Subscription".

Cancel Dialysis of Drugs Subscription on Android

1. Launch the PlayStore app and click the hamburger menu icon.
2. Select "Subscriptions" » tap "Dialysis of Drugs" » click "Cancel Subscription".
3. Your subscription to Dialysis of Drugs will now be canceled.

Cancel Dialysis of Drugs Subscription on PayPal

1. Sign in to your PayPal Account and click "Settings ".
2. Select "Payments" and click "Manage Automatic Payments".
3. Under Automatic Payments tab, click "Dialysis of Drugs" or "Renal Pharmacy Consultants LLC" » "Cancel".
4. You are now unsubscribed from Dialysis of Drugs

Cancel Dialysis of Drugs via Email

1. Open your email app
2. Provide all the relevant information regarding your account.
3. Provide a reason for the cancelation.
4. Send the email to betherlandson@redacted... Login to see email.

Cancel Subscription Directly on Dialysis of Drugs's Website

1. Visit their website - http://renalpharmacyconsultants.com and login to your account.
2. Goto your profile or account page and click "Billings" or "Subscriptions".
3. Click "Cancel" to remove your subscription.

1. The website provides specific information about factors that influence drug dialyzability and special considerations, such as CRRT, plasmapheresis and drugs of abuse.

2. For many drugs, including newly-approved medications, investigational agents and medications available in other countries, there have been no dialysis pharmacokinetic studies.

3. The guidelines contained in this application are designed to provide extensive, easy-to-read information regarding the dialyzability of drugs.

4. Variations in the duration of dialysis, blood and dialysate flow rates, dialysis membranes, and whether peritoneal dialysis is continuous or intermittent, will all affect drug removal.

5. No information is provided on drug dialyzability with continuous renal replacement therapy (CRRT) or with plasmapheresis.

6. For additional information on specific drugs, the reader should consult the primary literature.

7. These guidelines distinguish between conventional hemodialysis and high permeability (high-flux) hemodialysis where such data are available.

8. Users of this application are referred to for background and explanatory material to assist in the interpretation of the tabular data.

9. Users must be familiar with this information prior to using the content of this application.

10. Conditions of dialysis used in published studies may not reflect current dialysis practice and technology.

11. Numerous literature sources have been used in preparing the guidelines.

12. In some cases, the available data may conflict.

13. The website also includes a table presenting sieving coefficient data from in vitro and in vivo evaluations, which can be used to predict dosing requirements in CRRT, and a table regarding removal of drugs of abuse.